top of page

Parkinson's Disease

International Conference on

July 15, 2023
Live Conference

https://www.olcias.com/parkinson

Sessions:

  • Molecular Biology

  • Neuroanatomy

  • Neurophysiology & Electrophysiology

  • Neuropharmacology

  • Neuropsychology

  • Neuroimaging

  • Neurotoxicology

  • Clinical Phenomenology

  • Surgical and Pharmacological Treatment

  • Transplantation Studies

  • Relationship with Ageing

  • Epidemiology & Environmental Impact Factors

  • Rehabilitation

Parkinson disease is the neurological condition with the fastest global growth rate and is currently the main cause of disability. Over 6 million people now have Parkinson disease, up from 2 million in 1990. This number is expected to more than double to nearly 12 million by 2040, primarily due to ageing. The load could increase to nearly 17 million as a result of additional factors like longer life expectancy, a decline in smoking rates, and increased industrialization. Parkinson's disease has always been a rare condition. However, a pandemic of Parkinson's disease brought on by demography and the byproducts of industrialization will need for increased advocacy, targeted preparation, and creative strategies.

​

​

Dr. Tshetiz Dahal

Lugansk State Medical University

Ukraine

The strongest evidence yet that diabetes can alter Parkinson's disease development has been revealed by a recent study supported by Cure Parkinson's

Diabetes is a disorder that interferes with the body's chemical processes for converting food into energy in the cells. It is brought on by issues with the insulin protein. Insulin functions as a key to unlock cells, allowing glucose to enter. Insulin is necessary for our cells to absorb glucose, which is utilized as fuel. In diabetes, glucose levels in the blood rise because insulin no longer functions correctly, preventing it from being absorbed by cells.

The link between Parkinson's disease and diabetes has long been understood by researchers. Diabetes increases the risk of Parkinson's disease development compared to non-diabetics, while Parkinson's disease increases the risk of diabetes compared to non-diabetics.

The goal of this new study was to have a better understanding of how diabetes may affect the course of Parkinson's symptoms. They analyzed patient data over a 36-month period using information from the longitudinal Tracking Parkinson's research.

This is the largest study till date to show that diabetes is linked to a quicker progression of Parkinson's symptoms; they discovered that persons with Parkinson's who also had diabetes experienced more severe motor and non-motor symptoms over time.

​

​

Sanobar Shariff

Yerevan State Medical University

Armenia